Harvey I. Pass, MD
Professor of Surgery and Cardiothoracic Surgery
Director, Division of Thoracic Surgery and Thoracic Oncology
New York University Langone Medical Center and Cancer Center
New York University School of Medicine
New York, New York

Harvey I. Pass, MD is professor of surgery and cardiothoracic surgery, and the first director of the division of thoracic surgery and thoracic oncology at the New York University Langone Medical Center and Cancer Center in New York, New York. Dr Pass earned his medical degree from Duke University Medical School in Durham, North Carolina, and received his general surgery training at Duke University Medical Center and the University of Mississippi Medical Center in Jackson, Mississippi. Dr Pass’s cardiothoracic residency was at the Medical University of South Carolina in Charleston. He was the chief of Thoracic Oncology, Surgery Branch NCI from 1986-2006, and chief of Thoracic Oncology for the Karmanos Cancer Institute from 1996-2005.

Dr Pass’s research focuses on thoracic malignancies including lung cancer, pulmonary metastases, esophageal cancer, and mesothelioma. His laboratory at Bellevue Hospital is the home of the NCI-funded Early Detection Research Network Biomarker Discovery Laboratory for Mesothelioma, the Clinical CORE for the NCI’s funded Mesothelioma Pathogenesis Program Project, and the DOD CDMRP Mesothelioma glycomics grant.

Dr Pass serves as an ad hoc reviewer for publications including New England Journal of Medicine, JAMA, International Journal of Cancer, and Journal of Clinical Oncology. He has edited four editions of the reference text Lung Cancer: Principles and Practice. He has authored or coauthored over 330 peer-reviewed papers. He is a board member of the International Association for the Study of Lung Cancer, the Bonnie J. Addario Lung Cancer Foundation, and the International Mesothelioma Interest Group. He has been awarded the Castle Connolly’s America’s Top Doctors and Top Doctors for Cancer award for the last five years.